|
US7597886B2
(en)
|
1994-11-07 |
2009-10-06 |
Human Genome Sciences, Inc. |
Tumor necrosis factor-gamma
|
|
US7429646B1
(en)
|
1995-06-05 |
2008-09-30 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor-like 2
|
|
US7964190B2
(en)
|
1996-03-22 |
2011-06-21 |
Human Genome Sciences, Inc. |
Methods and compositions for decreasing T-cell activity
|
|
US6635743B1
(en)
|
1996-03-22 |
2003-10-21 |
Human Genome Sciences, Inc. |
Apoptosis inducing molecule II and methods of use
|
|
US6506569B1
(en)
|
1997-05-30 |
2003-01-14 |
Human Genome Sciences, Inc. |
Antibodies to human tumor necrosis factor receptor TR10
|
|
CA2292790A1
(en)
|
1997-05-30 |
1998-12-03 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor receptor tr10
|
|
EP0998561A4
(en)
*
|
1997-07-15 |
2004-08-18 |
Immunex Corp |
RECEPTOR DES TRAIL PROTEIN
|
|
US20030143632A1
(en)
*
|
1997-08-04 |
2003-07-31 |
Millennium Pharmaceuticals, Inc. |
Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
|
|
US20030175856A1
(en)
*
|
1997-08-26 |
2003-09-18 |
Genetech, Inc. |
Rtd receptor
|
|
ES2331900T3
(es)
*
|
1997-08-26 |
2010-01-19 |
Genentech, Inc. |
Receptor rtd.
|
|
EP2357192A1
(en)
|
1999-02-26 |
2011-08-17 |
Human Genome Sciences, Inc. |
Human endokine alpha and methods of use
|
|
EP1187842B1
(en)
*
|
1999-05-28 |
2006-04-26 |
Human Genome Sciences, Inc. |
Fc fusion proteins of the HUMAN TUMOR NECROSIS FACTOR RECEPTOR TR10
|
|
EP1210370A4
(en)
*
|
1999-08-12 |
2004-06-09 |
Human Genome Sciences Inc |
HUMAN TUMORNESCROSE FACTOR RECEPTOR TR16
|
|
EP2206720A1
(en)
|
2000-04-12 |
2010-07-14 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
CA2413160A1
(en)
|
2000-06-15 |
2001-12-20 |
Human Genome Sciences, Inc. |
Human tumor necrosis factor delta and epsilon
|
|
AU2001268427B2
(en)
|
2000-06-16 |
2007-03-29 |
Glaxosmithkline Intellectual Property Limited |
Antibodies that immunospecifically bind to blys
|
|
KR100436089B1
(ko)
*
|
2000-07-06 |
2004-06-14 |
설대우 |
분비성 재조합 트라이머형의 트레일 단백질 생산을 위한 디엔에이 카세트, 테트라사이클린/독시사이클린-유도성아데노-관련 바이러스 벡터, 이 둘의 조합, 및 이들을이용한 유전자 치료
|
|
MXPA03010747A
(es)
|
2001-05-25 |
2004-03-02 |
Human Genome Sciences Inc |
Anticuerpos que se unen inmunoespecificamente a receptores de ligando inductor de apoptosis relacionado con factor de necrosis tumoral.
|
|
US20030059850A1
(en)
*
|
2001-09-26 |
2003-03-27 |
Psychiatric Genomics, Inc. |
Fluorescence proximity assay
|
|
EP2261250B1
(en)
|
2001-12-21 |
2015-07-01 |
Human Genome Sciences, Inc. |
GCSF-Albumin fusion proteins
|
|
EA015860B1
(ru)
|
2005-10-13 |
2011-12-30 |
Хьюман Дженом Сайенсиз, Инк. |
Способы лечения аутоиммунных заболеваний при использовании антагониста нейтрокина-альфа
|
|
JP2009150799A
(ja)
*
|
2007-12-21 |
2009-07-09 |
Sysmex Corp |
分析装置、コンピュータプログラムおよび分析方法
|
|
CA2738472A1
(en)
|
2008-09-26 |
2010-04-22 |
Tocagen Inc. |
Gene therapy vectors and cytosine deaminases
|
|
SG10201509499RA
(en)
|
2010-11-19 |
2015-12-30 |
Eisai R&D Man Co Ltd |
Neutralizing anti-ccl20 antibodies
|
|
EP3623478A1
(en)
|
2012-10-25 |
2020-03-18 |
Tocagen Inc. |
Retroviral vector with mini-promoter cassette
|
|
ES2812208T3
(es)
|
2013-03-14 |
2021-03-16 |
Bristol Myers Squibb Co |
Combinación de un agonista de DR5 y un antagonista de anti-PD-1 y métodos de uso
|